semaglutide o tirzepatide vs in Atlanta Tirzepatide vs. Semaglutide for Weight

Patients reported that their daytime voiding frequency decreased from 9.5 times to 7.5 times per day, and nocturia (nighttime urination) resolved in 7 of 19 patients taking dulaglutide compared to only 1 of 16 patients on placebo

There may be direct pharmacological effects through central GLP-1 pathways, as well as indirect consequences of the medication's intended actions and associated side effects

[PubMed: 20020365] 251

Beneficiaries prescribed an eligible GLP-1 for a use coverable under standard Part D (e.g., Wegovy for CV risk reduction, Zepbound for OSA) do not qualify for that drug under the Bridge

In addition, catabolic genes Atrogin-1 and MuRF-1 were also not changed by the supplementation (data not shown)

doi: 63